Copper Rock Capital Partners LLC Sells 5,385 Shares of Hill-Rom Holdings Inc. (HRC)
Copper Rock Capital Partners LLC lowered its position in shares of Hill-Rom Holdings Inc. (NYSE:HRC) by 0.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 583,823 shares of the medical technology company’s stock after selling 5,385 shares during the period. Hill-Rom Holdings comprises about 2.3% of Copper Rock Capital Partners LLC’s portfolio, making the stock its 6th largest position. Copper Rock Capital Partners LLC owned 0.89% of Hill-Rom Holdings worth $35,590,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of HRC. Acrospire Investment Management LLC bought a new position in shares of Hill-Rom Holdings during the first quarter worth about $111,000. BlueMountain Capital Management LLC increased its position in shares of Hill-Rom Holdings by 36.5% in the second quarter. BlueMountain Capital Management LLC now owns 2,343 shares of the medical technology company’s stock worth $118,000 after buying an additional 626 shares during the last quarter. LS Investment Advisors LLC increased its position in shares of Hill-Rom Holdings by 67.4% in the second quarter. LS Investment Advisors LLC now owns 3,783 shares of the medical technology company’s stock worth $191,000 after buying an additional 1,523 shares during the last quarter. Bluestein R H & Co. bought a new position in shares of Hill-Rom Holdings during the second quarter worth about $202,000. Finally, Nine Chapters Capital Management LLC bought a new position in shares of Hill-Rom Holdings during the second quarter worth about $212,000. 83.11% of the stock is currently owned by institutional investors and hedge funds.
Shares of Hill-Rom Holdings Inc. (NYSE:HRC) traded down 0.18% on Thursday, reaching $61.75. 103,000 shares of the company’s stock were exchanged. The stock has a market cap of $4.04 billion, a price-to-earnings ratio of 63.59 and a beta of 1.14. Hill-Rom Holdings Inc. has a one year low of $42.99 and a one year high of $62.43. The company’s 50 day moving average is $59.62 and its 200-day moving average is $53.30.
Hill-Rom Holdings (NYSE:HRC) last announced its quarterly earnings results on Thursday, August 4th. The medical technology company reported $0.81 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.05. Hill-Rom Holdings had a return on equity of 16.62% and a net margin of 2.47%. The company earned $655.40 million during the quarter, compared to the consensus estimate of $647.75 million. During the same period in the previous year, the company posted $0.62 earnings per share. Hill-Rom Holdings’s revenue for the quarter was up 38.1% on a year-over-year basis. On average, analysts anticipate that Hill-Rom Holdings Inc. will post $3.33 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, September 30th. Shareholders of record on Friday, September 16th were issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date was Wednesday, September 14th. Hill-Rom Holdings’s payout ratio is presently 73.91%.
A number of research analysts have issued reports on HRC shares. Zacks Investment Research raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $64.00 price objective on the stock in a research report on Tuesday, August 9th. KeyCorp reissued a “buy” rating and set a $59.00 price objective on shares of Hill-Rom Holdings in a research report on Thursday, June 23rd. Finally, Morgan Stanley raised shares of Hill-Rom Holdings from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $54.00 to $62.00 in a research report on Thursday, June 16th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Hill-Rom Holdings has an average rating of “Buy” and a consensus price target of $62.20.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.
Receive News & Stock Ratings for Hill-Rom Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc. and related stocks with our FREE daily email newsletter.